We are live on
!
Find out more
ICM
Islay Capital Management Portfolio holdings
AUM
$197M
1-Year Est. Return
19.56%
This Fund
S&P 500
This Quarter
Est. Return
+5.91%
1 Year Est. Return
+19.56%
3 Year Est. Return
+65.19%
5 Year Est. Return
+82.58%
10 Year Est. Return
–
AUM
$124M
AUM Growth
+$2.36M
(+1.9%)
Cap. Flow
-$4.08M
Cap. Flow
% of AUM
-3.3%
Top 10 Holdings %
Top 10 Hldgs %
43.44%
Holding
324
New
50
Increased
34
Reduced
80
Closed
42
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco S&P 500 Equal Weight Technology ETF
RSPT
|
+$1.95M |
| 2 |
Johnson & Johnson
JNJ
|
+$705K |
| 3 |
Fidelity Nasdaq Composite Index ETF
ONEQ
|
+$619K |
| 4 |
IFLN
Invesco Bloomberg Enhanced Fallen Angels ETF
IFLN
|
+$376K |
| 5 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$240K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab US Dividend Equity ETF
SCHD
|
+$1.83M |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$1.15M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.03M |
| 4 |
HTLF
Heartland Financial USA, Inc.
HTLF
|
+$791K |
| 5 |
State Street SPDR Portfolio S&P 600 Small Cap ETF
SPSM
|
+$621K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.81% |
| 2 | Financials | 6.06% |
| 3 | Healthcare | 4.69% |
| 4 | Consumer Discretionary | 3.68% |
| 5 | Consumer Staples | 3.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Applied Materials
AMAT
$403B
| $218K | 0.18% |
1,530
+186
| +14% | +$25K |
|
77
Whirlpool
WHR
$2.43B
| $212K | 0.17% |
972
-420
| -30% | -$97.8K |
|
78
AT&T
T
$159B
| $207K | 0.17% |
9,506
| – | – |
|
79
Teladoc Health
TDOC
$1.22B
| $198K | 0.16% |
1,190
-265
| -18% | -$42.9K |
|
80
Schwab U.S Small- Cap ETF
SCHA
$22.7B
| $181K | 0.15% |
6,960
-428
| -6% | -$10.9K |
|
81
Emerson Electric
EMR
$83.9B
| $178K | 0.14% |
1,853
+292
| +19% | +$27.5K |
|
82
Texas Instruments
TXN
$252B
| $174K | 0.14% |
905
+121
| +15% | +$22.7K |
|
|
APLS
83
DELISTED
Apellis Pharmaceuticals
APLS
| $167K | 0.14% |
+2,648
| New | +$137K |
|
|
SBR
84
Sabine Royalty Trust
SBR
$1.06B
| $161K | 0.13% |
4,000
| – | – |
|
85
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.6B
| $161K | 0.13% |
1,942
| – | – |
|
86
NovaGold Resources
NG
$2.56B
| $160K | 0.13% |
20,000
| – | – |
|
87
Cactus
WHD
$5.21B
| $159K | 0.13% |
4,325
| – | – |
|
88
Denali Therapeutics
DNLI
$3.65B
| $158K | 0.13% |
+2,013
| New | +$125K |
|
89
Elevance Health
ELV
$81.5B
| $155K | 0.13% |
407
| – | – |
|
90
BellRing Brands
BRBR
$1.44B
| $151K | 0.12% |
4,818
-51
| -1% | -$1.39K |
|
91
Cardinal Health
CAH
$53.9B
| $148K | 0.12% |
2,591
| – | – |
|
92
Gen Digital
GEN
$16.4B
| $147K | 0.12% |
+5,390
| New | +$134K |
|
93
Avantor
AVTR
$9.32B
| $142K | 0.11% |
3,998
-246
| -6% | -$7.96K |
|
94
Houlihan Lokey
HLI
$8.77B
| $141K | 0.11% |
+1,720
| New | +$125K |
|
95
Revvity
RVTY
$12.6B
| $138K | 0.11% |
+894
| New | +$126K |
|
96
iShares Emerging Markets Dividend ETF
DVYE
$1.22B
| $135K | 0.11% |
3,487
| – | – |
|
97
Bath & Body Works
BBWI
$4.06B
| $134K | 0.11% |
+2,301
| New | +$124K |
|
98
Deere & Co
DE
$160B
| $134K | 0.11% |
380
| – | – |
|
99
Carrier Global
CARR
$51B
| $133K | 0.11% |
+2,746
| New | +$123K |
|
100
Deckers Outdoor
DECK
$13.2B
| $133K | 0.11% |
+2,082
| New | +$117K |
|
Similar funds
RC
SFG
ECP
GL
IMC
OCM
SWM
SCM
Islay Capital Management's Q2 2021 Portfolio in Review
As of Q2 2021, Islay Capital Management held 324 positions worth $124M, up 1.9% from $121M the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Islay Capital Management withdrew a net $4.08M in Q2 2021, closing 42 positions and reducing 80 holdings. Its most notable exit was Humana, an estimated $273K position sold in full.
By sector, the portfolio is most concentrated in Technology at 7.8% of assets, up from 6.8% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Islay Capital Management opened a new position in Apellis Pharmaceuticals worth $167K.
- Islay Capital Management's largest Q2 2021 buy was Apellis Pharmaceuticals: 2,648 shares worth $167K.
- Islay Capital Management added most to Invesco S&P 500 Equal Weight Technology ETF in Q2 2021, an estimated $1.95M increase.
- Islay Capital Management's biggest Q2 2021 reduction was Schwab US Dividend Equity ETF, cutting an estimated $1.83M.
- Islay Capital Management fully exited Humana in Q2 2021, selling an estimated $273K.
- Islay Capital Management's ten largest holdings make up 43% of its $124M portfolio in Q2 2021.
- Islay Capital Management opened 50 new positions and closed 42 in Q2 2021.
- Islay Capital Management's portfolio value rose 1.9% quarter-over-quarter to $124M.
Based on Islay Capital Management's 13F filing for Q2 2021, filed 2 Aug 2021.